Company / Operating Cash Flow per Share
LIPELLA PHARMACEUTICALS INC. Operating Cash Flow per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$5.22
FY2024
5-year range
-$5.22 / -$0.47
FY2022-FY2024
Trend
-851.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -852% YoY in FY2024, a notable deviation from the 2-year average annual change of -434%.
Based on SEC 10-K filings.
-5.22 in FY2024.
Declined from $-0.47 to $-5.22 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 851.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$5.22 | -851.9% |
| FY2023 | -$0.55 | -15.8% |
| FY2022 | -$0.47 | - |
As of FY2024 · SEC Form 10-K · Last checked Jun 29, 2026